The pathogenesis of Helicobacter pylori-induced gastro-duodenal diseases

Annual Review of Pathology

Volumn 1, Issue , 2006, Pages 63-96

  Atherton, John C ^a  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

Author keywords

Duodenal ulcer; Gastric adenocarcinoma; Gastric MALT lymphoma; Gastric ulcer; Helicobacter pylori; Reflux esophagitis

Indexed keywords

ADHESIN; VACUOLATING TOXIN; VIRULENCE FACTOR;

ACHLORHYDRIA; BARRETT ESOPHAGUS; CANCER RISK; CELL DAMAGE; CYTOKINE RELEASE; DISEASE ASSOCIATION; DNA POLYMORPHISM; DUODENUM DISEASE; EPITHELIUM CELL; ESOPHAGUS CARCINOMA; GASTRITIS; GASTROESOPHAGEAL REFLUX; GASTROINTESTINAL DISEASE; HELICOBACTER PYLORI; HYPERGASTRINEMIA; IMMUNE RESPONSE; INFLAMMATION; PEPTIC ULCER; PREVALENCE; PRIORITY JOURNAL; REVIEW; STOMACH ADENOCARCINOMA; STOMACH LYMPHOMA; TH1 CELL;

EID: 33645740999     PISSN: 15534006     EISSN: 15534014     Source Type: Book Series    
DOI: 10.1146/annurev.pathol.1.110304.100125     Document Type: Review

References (252)

1. Franchini M, Veneri D. 2004. Helicobacter pylori infection and immune thrombocytopenic purpura: an update. Helicobacter 9:342-46
2. Jackson S, Beck PL, Pineo GF, Poon MC. 2005. Helicobacter pylori eradication: novel therapy for immune thrombocytopenic purpura? A review of the literature. Am. J. Hematol. 78:142-50
3. Pellicano R, Fagoonee S, Rizzetto M, Ponzetto A. 2003. Helicobacter pylori and coronary heart disease: Which directions for future studies? Crit. Rev. Microbiol. 29:351-59
4. Gasbarrini A, Carloni E, Gasbarrini G, Chisholm SA. 2004. Helicobacter pylori and extragastric diseases - other Helicobacters. Helicobacter 9:57-66
5. Morris A, Nicholson G. 1987. Ingestion of Campylobacter-Pyloridis causes gastritis and raised fasting gastric Ph. Am. J. Gastroenterol. 82:192-99
6. Graham DY, Alpert LC, Smith JL, Yoshimura HH. 1988. Iatrogenic Campylobacter-Pylori infection is a cause of epidemic achlorhydria. Am. J. Gastroenterol. 83:974-80
7. Blaser MJ, Atherton JC. 2004. Helicobacter pylori persistence: biology and disease. J. Clin. Invest. 113:321-33
8. Tomb JF, White O, Kerlavage AR, Clayton RA, Sutton GG, et al. 1997. The complete genome sequence of the gastric pathogen Helicobacter pylori. Nature 388:539-47
9. Aim RA, Ling LSL, Moir DT, King BL, Brown ED, et al. 1999. Genomic-sequence comparison of two unrelated isolates of the human gastric pathogen Helicobacter pylori. Nature 397:176-80
10. Kavermann H, Burns BP, Angermuller K, Odenbreit S, Fischer W, et al. 2003. Identification and characterization of Helicobacter pylori genes essential for gastric colonization. J. Exp. Med. 197:813-22
11. Terry K, Williams SM, Connolly L, Ottemann KM. 2005. Chemotaxis plays multiple roles during Helicobacter pylori animal infection. Infect. Immun. 73:803-11
12. Waidner B, Greiner S, Odenbreit S, Kavermann H, Velayudhan J, et al. 2002. Essential role of ferritin Pfr in Helicobacter pylori iron metabolism and gastric colonization. Infect. Immun. 70:3923-29
13. Wen Y, Marcus EA, Matrubutham U, Gleeson MA, Scott DR, et al. 2003. Acid-adaptive genes of Helicobacter pylori. Infect. Immun. 71:5921-39
14. McGowan CC, Necheva AS, Forsyth MH, Cover TL, Blaser MJ. 2003. Promoter analysis of Helicobacter pylori genes with enhanced expression at low pH. Mol. Microbiol. 48:1225-39
15. Weeks DL, Eskandari S, Scott DR, Sachs G. 2000. A H+-gated urea channel: the link between Helicobacter pylori urease and gastric colonization. Science 287:482-85
16. Atherton JC, Blaser MJ. 2004. Chapter 154: Helicobacter pylori infections. In Harrison's Principals of Internal Medicine, ed. DL Kasper, E Braunwald, AS Fauci, SL HAuser, DL Longo, JL Jameson, pp. 886-89. New York: McGraw-Hill. 16th ed.
17. Clyne M, Dillon P, Daly S, O'Kennedy R, May FEB, et al. 2004. Helicobacter pylori interacts with the human single-domain trefoil protein TFF1. Proc. Natl. Acad. Sci. USA 101:7409-14
18. Kawakubo M, Ito Y, Okimura Y, Kobayashi M, Sakura K, et al. 2004. Natural antibiotic function of a human gastric mucin against Helicobacter pylori infection. Science 305:1003-6
19. Schreiber S, Konradt M, Groll C, Scheid P, Hanauer G, et al. 2004. The spatial orientation of Helicobacter pylori in the gastric mucus. Proc. Natl. Acad. Sci. USA 101:5024-29
20. Kim N, Marcus EA, Wen Y, Weeks DL, Scott DR, et al. 2004. Genes of Helicobacter pylori regulated by attachment to AGS cells. Infect. Immun. 72:2358-68
21. Kwok T, Backen S, Schwarz H, Berger J, Meyer TF. 2002. Specific entry of Helicobacter pylori into cultured gastric epithelial cells via a zipper-like mechanism. Infect. Immun. 70:2108-20
22. Amieva MR, Salama NR, Tompkins LS, Falkow S. 2002. Helicobacter pylori enter and survive within multivesicular vacuoles of epithelial cells. Cell. Microbiol. 4:677-90
23. Rittig MG, Shaw B, Letley DP, Thomas RJ, Argent RH, et al. 2003. Helicobacter pylori-induced homotypic phagosome fusion in human monocytes is independent of the bacterial vacA and cag status. Cell. Microbiol. 5:887-99
24. Odenbreit S, Gebert B, Puls J, Fischer W, Haas R. 2001. Interaction of Helicobacter pylori with professional phagocytes: role of the cag pathogenicity island and translocation, phosphorylation and processing of CagA. Cell. Microbiol. 3:21-31
25. Ohta T, Shibata H, Kawamori T, Iimuro M, Sugimura T, et al. 2001. Marked reduction of Helicobacter pylori-induced gastritis by urease inhibitors, acetohydroxamic acid and flurofamide, in Mongolian gerbils. Biochem. Biophys. Res. Commun. 285:728-33
26. Harris PR, Ernst PB, Kawabata S, Kiyono H, Graham MF, et al. 1998. Recombinant Helicobacter pylori urease activates primary mucosal macrophages. J. Infect. Dis. 178:1516-20
27. Satin B, Del Giudice G, Della Bianca V, Dusi S, Laudanna C, et al. 2000. The neutrophil-activating protein (HP-NAP) of Helicobacter pylori is a protective antigen and a major virulence factor. J. Exp. Med. 191:1467-76
28. Tonello F, Dundon WG, Satin B, Molinari M, Tognon G, et al. 1999. The Helicobacter pylori neutrophil-activating protein is an iron-binding protein with dodecameric structure. Mol. Microbiol. 34:238-46
29. Backhed F, Rokbi B, Torstensson E, Zhao Y, Nilsson C, et al. 2003. Gastric mucosal recognition of Helicobacter pylori is independent of Toll-like receptor 4. J. Infect. Dis. 187:829-36
30. Smith MF, Mitchell A, Li GL, Ding S, Fitzmaurice AM, et al. 2003. Toll-like receptor (TLR) 2 and TLR5, but not TLR4, are required for Helicobacter pylori-induced NF-kappa B activation and chemokine expression by epithelial cells. J. Biol. Chem. 278:32552-60
31. Gewirtz AT, Yu Y, Krishna US, Israel DA, Lyons SL, et al. 2004. Helicobacter pylori flagellin evades toll-like receptor 5-mediated innate immunity. J. Infect. Dis. 189:1914-20
32. Gobert AP, McGee D, Akhtar M, Mendz GL, Newton JC, et al. 2001. Helicobacter pylori arginase inhibits nitric oxide production by eukaryotic cells: a strategy for bacterial survival. Gut 49:429
33. Schmausser B, Andrulis M, Endrich S, Lee SK, Josenhans C, et al. 2004. Expression and subcellular distribution of toll-like receptors TLR4, TLR5 and TLR9 on the gastric epithelium in Helicobacter pylori infection. Clin. Exp. Immunol. 136:521-26
34. Alamuri P, Maier RJ. 2004. Methionine sulphoxide reductase is an important antioxidant enzyme in the gastric pathogen Helicobacter pylori. Mol. Microbiol. 53:1397-406
35. Suerbaum S, Smith JM, Bapumia K, Morelli G, Smith NH, et al. 1998. Free recombination within Helicobacter pylori. Proc. Natl. Acad. Sci. USA 95:12619-24
36. Israel DA, Salama N, Krishna U, Rieger UM, Atherton JC, et al. 2001. Helicobacter pylori genetic diversity within the gastric niche of a single human host. Proc. Natl. Acad. Sci. USA 98:14625-30
37. Falush D, Kraft C, Taylor NS, Correa P, Fox JG, et al. 2001. Recombination and mutation during long-term gastric colonization by Helicobacter pylori: estimates of clock rates, recombination size, and minimal age. Proc. Natl. Acad. Sci. USA 98:15056-61
38. Aspholm-Hurtig M, Dailide G, Lahmann M, Kalia A, Ilver D, et al. 2004. Functional adaptation of BabA, the H. pylori ABO blood group antigen binding adhesin. Science 305:519-22
39. Robinson K, Loughlin MF, Potter R, Jenks PJ. 2005. Host adaptation and immune modulation are mediated by homologous recombination in Helicobacter pylori. J. Infect. Dis. 191:579-87
40. Hansson LE, Nyren O, Hsing AW, Bergstrom R, Josefsson S, et al. 1996. The risk of stomach cancer in patients with gastric or duodenal ulcer disease. New Engl. J. Med. 335:242-49
41. Censini S, Lange C, Xiang ZY, Crabtree JE, Ghiara P, et al. 1996. cag, a pathogenicity island of Helicobacter pylori, encodes type I-specific and disease-associated virulence factors. Proc. Natl. Acad. Sci. USA 93:14648-53
42. Nilsson C, Sillen A, Eriksson L, Strand ML, Enroth H, et al. 2003. Correlation between cag pathogenicity island composition and Helicobacter pylori-associated gastroduodenal disease. Infect. Immun. 71:6573-81
43. Crabtree JE, Taylor JD, Wyatt JI, Heatley RV, Shallcross TM, et al. 1991. Mucosal Iga recognition of Helicobacter pylori 120-kDa protein, peptic ulceration, and gastric pathology. Lancet 338:332-35
44. Nomura AMY, Perez-Perez GI, Lee J, Stemmermann G, Blaser MJ. 2002. Relation between Helicobacter pylori cagA status and risk of peptic ulcer disease. Am. J. Epidemiol. 155:1054-59
45. Blaser MJ, Perezperez GI, Kleanthous H, Cover TL, Peek RM, et al. 1995. Infection with Helicobacter pylori strains possessing caga is associated with an increased risk of developing adenocarcinoma of the stomach. Cancer Res. 55:2111-15
46. Figueiredo C, Machado JC, Pharoah P, Seruca R, Sousa S, et al. 2002. Helicobacter pylori and interleukin 1 genotyping: an opportunity to identify high-risk individuals for gastric carcinoma. J. Natl. Cancer Inst. 94:1680-87
47. Rohde M, Puls J, Buhrdorf R, Fischer W, Haas R. 2003. A novel sheathed surface organelle of the Helicobacter pylori cag type IV secretion system. Mol. Microbiol. 49:219-34
48. Tanaka J, Suzuki T, Mimuro H, Sasakawa C. 2003. Structural definition on the surface of Helicobacter pylori type IV secretion apparatus. Cell. Microbiol. 5:395-404
49. Segal ED, Cha J, Lo J, Falkow S, Tompkins LS. 1999. Altered states: involvement of phosphorylated CagA in the induction of host cellular growth changes by Helicobacter pylori. Proc. Natl. Acad. Sci. USA 96:14559-64
50. Asahi M, Azuma T, Ito S, Ito Y, Suto H, et al. 2000. Helicobacter pylori CagA protein can be tyrosine phosphorylated in gastric epithelial cells. J. Exp. Med. 191:593-602
51. Odenbreit S, Puls J, Sedlmaier B, Gerland E, Fischer W, et al. 2000. Translocation of Helicobacter pylori CagA into gastric epithelial cells by type IV secretion. Science 287:1497-500
52. Stein M, Rappuoli R, Covacci A. 2000. Tyrosine phosphorylation of the Helicobacter pylori CagA antigen after cag-driven host cell translocation. Proc. Natl. Acad. Sci. USA 97:1263-68
53. Stein M, Bagnoli F, Halenbeck R, Rappuoli R, Fand WJ, et al. 2002. c-Src/Lyn kinases activate Helicobacter pylori CagA through tyrosine phosphorylation of the EPIYA motifs. Mol. Microbiol. 43:971-80
54. Selbach M, Moese S, Hauck CR, Meyer TF, Backert S. 2002. Src is the kinase of the Helicobacter pylori CagA protein in vitro and in vivo. J. Biol. Chem. 277:6775-78
55. Amieva MR, Vogelmann R, Covacci A, Tompkins LS, Nelson WJ, et al. 2003. Disruption of the epithelial apical-junctional complex by Helicobacter pylori CagA. Science 300:1430-34
56. Churin Y, Al-Ghoul L, Kepp O, Meyer TE, Birchmeier W, et al. 2003. Helicobacter pylori CagA protein targets the c-Met receptor and enhances the motogenic response. J. Cell. Biol. 161:249-55
57. El-Etr SH, Mueller A, Tompkins LS, Falkow S, Merrell DS. 2004. Phosphorylation-independent effects of CagA during interaction between Helicobacter pylori and T84 polarized monolayers. J. Infect. Dis. 190:1516-23
58. Higashi H, Nakaya A, Tsutsumi R, Yokoyama K, Fujii Y, et al. 2004. Helicobacter pylori CagA induces Ras-independent morphogenetic response through SHP-2 recruitment and activation. J. Biol. Chem. 279:17205-16
59. Higashi H, Tsutsumi R, Fujita A, Yamazaki S, Asaka M, et al. 2002. Biological activity of the Helicobacter pylori virulence factor CagA is determined by variation in the tyrosine phosphorylation sites. Proc. Natl. Acad. Sci. USA 99:14428-33
60. Hirata Y, Maeda S, Mitsuno Y, Tateishi K, Yanai A, et al. 2002. Helicobacter pylori CagA protein activates serum response element-driven transcription independently of tyrosine phosphorylation. Gastroenterology 123:1962-71
61. Keates S, Sougioultzis S, Keates AC, Zhao DZ, Peek RM, et al. 2001. cag plus Helicobacter pylori induce transactivation of the epidermal growth factor receptor in AGS gastric epithelial cells. J. Biol. Chem. 276:48127-34
62. Meyer-ter-Vehn T, Covacci A, Kist M, Pahl HL. 2000. Helicobacter pylori activates mitogen-activated protein kinase cascades and induces expression of the proto-oncogenes c-fos and c-jun. J. Biol. Chem. 275:16064-72
63. Mitsuno Y, Maeda S, Yoshida H, Hirata Y, Ogura K, et al. 2002. Helicobacter pylori activates the proto-oncogene c-fos through SRE transactivation. Biochem. Biophys. Res. Commun. 291:868-74
64. Mimuro H, Suzuki T, Tanaka J, Asahi M, Haas R, et al. 2002. Grb2 is a key mediator of Helicobacter pylori CagA protein activities. Mol. Cell. 10:745-55
65. Naumann M, Wessler S, Bartsch C, Wieland B, Covacci A, et al. 1999. Activation of activator protein 1 and stress response kinases in epithelial cells colonized by Helicobacter pylori encoding the cag pathogenicity island. J. Biol. Chem. 274:31655-62
66. Selbach M, Moese S, Meyer TF, Backert S. 2002. Functional analysis of the Helicobacter pylori cag pathogenicity island reveals both VirD4-CagA-dependent and VirD4-CagA-independent mechanisms. Infect. Immun. 70:665-71
67. Tsutsumi R, Higashi H, Higuchi M, Olcada M, Hatakeyama M. 2003. Attenuation of Helicobacter pylori CagA-SHP-2 signaling by interaction betwwen CagA and C-terminal Src kinase. J. Biol. Chem. 278:3664-70
68. Yamazaki S, Yamakawa A, Ito Y, Ohtani M, Higashi H, et al. 2003. The CagA protein of Helicobacter pylori is translocated into epithelial cells and binds to SHP-2 in human gastric mucosa. J. Infect. Dis. 187:334-37
69. Moese S, Selbach M, Kwok T, Brinkmann V, Konig W, et al. 2004. Helicobacter pylori induces AGS cell motility and elongation via independent signaling pathways. Infect. Immun. 72:3646-9
70. Bebb JR, Letley DP, Rhead JL, Atherton JC. 2003. Helicobacter pylori supernatants cause epithelial cytoskeletal disruption that is bacterial strain and epithelial cell line dependent but not toxin VacA dependent. Infect. Immun. 71:3623-27
71. Segal ED, Falkow S, Tompkins LS. 1996. Helicobacter pylori attachment to gastric cells induces cytoskeletal rearrangements and tyrosine phosphorylation of host cell proteins. Proc. Natl. Acad. Sci. USA 93:1259-64
72. Moss SF, Sordillo EM, Abdalla AM, Makarov V, Hanzely Z, et al. 2001. Increased gastric epithelial cell apoptosis associated with colonization with cagA plus Helicobacter pylori strains. Cancer Res. 61:1406-11
73. Peek RM Jr, Moss SF, Tham KT, Perez-Perez GI, Wang S, et al. 1997. Helicobacter pylori cagA+ strains and dissociation of gastric epithelial cell proliferation from apoptosis. J. Natl. Cancer Inst. 89:863-68
74. Argent RH, Kidd M, Owen RJ, Thomas RJ, Limb MC, et al. 2004. Determinants and consequences of different levels of CagA phosphorylation for clinical isolates of Helicobacter pylori. Gastroenterology 127:514-23
75. Yamaoka Y, El-Zimaity HM, Gutierrez O, Figura N, Kim JG, et al. 1999. Relationship between the cagA 3' repeat region of Helicobacter pylori, gastric histology, and susceptibility to low pH. Gastroenterology 117:342-49
76. Azuma T, Yamakawa A, Yamazaki S, Fukuta K, Ohtani M, et al. 2002. Correlation between variation of the 3' region of the cagA gene in Helicobacter pylori and disease outcome in Japan. J. Infect. Dis. 186:1621-30
77. Azuma T, Yamazaki S, Yamakawa A, Ohtani M, Muramatsu A, et al. 2004. Association between diversity in the Src homology 2 domain-containing tyrosine phosphatase binding site of Helicobacter pylori CagA protein and gastric atrophy and cancer. J. Infect. Dis. 189:820-27
78. Fischer W, Puls J, Buhrdorf R, Gebert B, Odenbreit S, et al. 2001. Systematic mutagenesis of the Helicobacter pylori cag pathogenicity island: essential genes for CagA translocation in host cells and induction of interleukin-8. Mol. Microbiol. 42:1337-48
79. Viala J, Chaput C, Boneca IG, Cardona A, Girardin SE, et al. 2004. Nodi responds to peptidoglycan delivered by the Helicobacter pylori cag pathogenicity island. Nat. Immun. 5:1166-74
80. Maeda S, Yoshida H, Ogura K, Mitsuno Y, Hirata Y, et al. 2000. H. pylori activates NF-kappa B through a signaling pathway involving I kappa B kinases, NF-kappa B-inducing kinase, TRAF2, and TRAF6 in gastric cancer cells. Gastroenterology 119:97-108
81. Mori N, Sato H, Hayashibara T, Senba M, Geleziunas R, et al. 2003. Helicobacter pylori induces matrix metalloproteinase-9 through activation of nuclear factor kappaB. Gastroenterology 124:983-92
82. Wada A, Ogushi K, Kimura T, Hojo H, Mori N, et al. 2001. Helicobacter pylori-mediated transcriptional regulation of the human beta-defensin 2 gene requires NF-kappa B. Cell. Microbiol. 3:115-23
83. Yanai A, Hirata Y, Mitsuno Y, Maeda S, Shibata W, et al. 2003. Helicobacter pylori induces antiapoptosis through nuclear factor-kappa B activation. J. Infect. Dis. 188:1741-51
84. Bebb JR, Letley DP, Thomas RJ, Aviles F, Collins HM, et al. 2003. Helicobacter pylori upregulates matrilysin (MMP-7) in epithelial cells in vivo and in vitro in a Cag dependent manner. Gut 52:1408-13
85. Ogura K, Maeda S, Nakao M, Watanabe T, Tada M, et al. 2000. Virulence factors of Helicobacter pylori responsible for gastric diseases in Mongolian gerbil. J. Exp. Med. 192:1601-10
86. Kersulyte D, Chalkauskas H, Berg DE. 1999. Emergence of recombinant strains of Helicobacter pylori during human infection. Mol. Microbiol. 31:31-43
87. Aras RA, Lee Y, Kim SK, Israel D, Peek RM, et al. 2003. Natural variation in populations of persistently colonizing bacteria affect human host cell phenotype. J. Infect. Dis. 188:486-96
88. Cover TL, Tummuru MK, Cao P, Thompson SA, Blaser MJ. 1994. Divergence of genetic sequences for the vacuolating cytotoxin among Helicobacter pylori strains. J. Biol. Chem. 269:10566-73
89. Atherton JC, Cao P, Peek RM, Tummuru MKR, Blaser MJ, et al. 1995. Mosaicism in vacuolating cytotoxin alleles of Helicobacter pylori-association of specific vacA types with cytotoxin production and peptic ulceration. J. Biol. Chem. 270:17771-77
90. Letley DP, Lastovica A, Louw JA, Hawkey CJ, Atherton JC. 1999. Allelic diversity of the Helicobacter pylori vacuolating cytotoxin gene in South Africa: rarity of the vacA s1a genotype and natural occurrence of an s2/m1 allele. J. Clin. Microbiol. 37:1203-5
91. Letley DP, Rhead JL, Twells RJ, Dove B, Atherton JC. 2003. Determinants of non-toxicity in the gastric pathogen Helicobacter pylori. J. Biol. Chem. 278:26734-41
92. Pagliaccia C, de Bernard M, Lupetti P, Ji X, Burroni D, et al. 1998. The m2 form of the Helicobacter pylori cytotoxin has cell type-specific vacuolating activity. Proc. Natl. Acad. Sci. USA 95:10212-17
93. Atherton JC, Cao P, Peek RM Jr, Tummuru MK, Blaser MJ, et al. 1995. Mosaicism in vacuolating cytotoxin alleles of Helicobacter pylori. Association of specific vacA types with cytotoxin production and peptic ulceration. J. Biol. Chem. 270:17771-77
94. Atherton JC, Peek RM Jr, Tham KT, Cover TL, Blaser MJ. 1997. Clinical and pathological importance of heterogeneity in vacA, the vacuolating cytotoxin gene of Helicobacter pylori. Gastroenterology 112:92-99
95. Atherton JC, Cover TL, Papini E, Telford JL. 2001. Vacuolating cytotoxin. In Helicobacter Pylori: Physiology and Genetics, ed. HLT Mobley, GL Mendz, SL Hazell, pp. 97-110. Washington: ASM Press.
96. van Doom LJ, Figueiredo C, Sanna R, Pena S, Midolo P, et al. 1998. Expanding allelic diversity of Helicobacter pylori vacA. J. Clin. Microbiol. 36:2597-603
97. Kidd M, Lastovica AJ, Atherton JC, Louw JA. 1999. Heterogeneity in the Helicobacter pylori vacA and cagA genes: association with gastroduodenal disease in South Africa? Gut 45:499-502
98. Miehlke S, Kirsch C, Agha-Amiri K, Gunther T, Lehn N, et al. 2000. The Helicobacter pylori vacA s1, m1 genotype and cagA is associated with gastric carcinoma in Germany. Int. J. Cancer 87:322-27
99. Figueiredo C, Van Doom LJ, Nogueira C, Soares JM, Pinho C, et al. 2001. Helicobacter pylori genotypes are associated with clinical outcome in Portuguese patients and show a high prevalence of infections with multiple strains. Scand. J. Gastroenterol. 36:128-35
100. Ito Y, Azuma T, Ito S, Suto H, Miyaji H, et al. 1998. Full-length sequence analysis of the vacA gene from cytotoxic and noncytotoxic Helicobacter pylori. J. Infect. Dis. 178:1391-98
101. Telford JL, Ghiara P, Dellorco M, Comanducci M, Burroni D, et al. 1994. Gene structure of the Helicobacter pylori cytotoxin and evidence of its key role in gastric disease. J. Exp. Med. 179:1653-58
102. Ilver D, Barone S, Mercati D, Lupetti P, Telford JL. 2004. Helicobacter pylori toxin VacA is transferred to host cells via a novel contact-dependent mechanism. Cell. Microbiol. 6:167-74
103. Yahiro K, Wada A, Nakayama M, Kimura T, Ogushi K, et al. 2003. Protein-tyrosine phosphatase alpha, RPTP alpha, is a Helicobacter pylori VacA receptor. J. Biol. Chem. 278:19183-89
104. Yahiro K, Niidome T, Kimura M, Hatakeyama T, Aoyagi H, et al. 1999. Activation of Helicobacter pylori VacA toxin by alkaline or acid conditions increases its binding to a 250-kDa receptor protein-tyrosine phosphatase beta. J. Biol. Chem. 274:36693-99
105. Padilla PI, Wada A, Yahiro K, Kimura M, Niidome T, et al. 2000. Morphologic differentiation of HL-60 cells is associated with appearance of RPTPbeta and induction of Helicobacter pylori VacA sensitivity. J. Biol. Chem. 275:15200-6
106. Seto K, Hayashi-Kuwabara Y, Yoneta T, Suda H, Tamaki H. 1998. Vacuolation induced by cytotoxin from Helicobacter pylori is mediated by the EGF receptor in HeLa cells. FEBS Lett. 431:347-50
107. Schraw W, Li Y, McClain MS, van der Goot FG, Cover TL. 2002. Association of Helicobacter pylori vacuolating toxin (VacA) with lipid rafts. J. Biol. Chem. 277:34642-50
108. Kuo CH, Wang WC. 2003. Binding and internalization of Helicobacter pylori VacA via cellular lipid rafts in epithelial cells. Biochem. Biophys. Res. Commun. 303:640-44
109. McClain MS, Schraw W, Ricci V, Boquet P, Cover TL. 2000. Acid activation of Helicobacter pylori vacuolating cytotoxin (VacA) results in toxin internalization by eukaryotic cells. Mol. Microbiol. 37:433-42
110. Ricci V, Sommi P, Fiocca R, Necchi V, Romano M, et al. 2002. Extracellular pH modulates Helicobacter pylori-induced vacuolation and VacA toxin internalization in human gastric epithelial cells. Biochem. Biophys. Res. Commun. 292:167-74
111. Czajkowsky DM, Iwamoto H, Cover TL, Shao ZF. 1999. The vacuolating toxin from Helicobacter pylori forms hexameric pores in lipid bilayers at low pH. Proc. Natl. Acad. Sci. USA 96:2001-6
112. Szabo I, Brutsche S, Tombola F, Moschioni M, Satin B, et al. 1999. Formation of anion-selective channels in the cell plasma membrane by the toxin VacA of Helicobacter pylori is required for its biological activity. EMBO J. 18:5517-27
113. Tombola F, Morbiato L, Del Giudice G, Rappuoli R, Zoratti M, et al. 2001. The Helicobacter pylori VacA toxin is a urea permease that promotes urea diffusion across epithelia. J. Clin. Invest. 108:929-37
114. Papini E, Debernard M, Milia E, Bugnoli M, Zerial M, et al. 1994. Cellular vacuoles induced by Helicobacter pylori originate from late endosomal compartments. Proc. Natl. Acad. Sci. USA 91:9720-24
115. Papini E, Satin B, Norais N, de Bernard M, Telford JL, et al. 1998. Selective increase of the permeability of polarized epithelial cell monolayers by Helicobacter pylori vacuolating toxin. J. Clin. Invest. 102:813-20
116. Merrell DS, Thompson LJ, Kim CC, Mitchell H, Tompkins LS, et al. 2003. Growth phase-dependent response of Helicobacter pylori to iron starvation. Infect. Immun. 71:6510-25
117. Kuck D, Kolmerer B, Iking-Konert C, Krammer PH, Stremmel W, et al. 2001. Vacuolating cytotoxin of Helicobacter pylori induces apoptosis in the human gastric epithelial cell line AGS. Infect. Immun. 69:5080-87
118. Cover TL, Krishna US, Israel DA, Peek RM Jr. 2003. Induction of gastric epithelial cell apoptosis by Helicobacter pylori vacuolating cytotoxin. Cancer Res. 63:951-57
119. Galmiche A, Rassow J, Doye A, Cagnol S, Chambard JC, et al. 2000. The N-terminal 34 kDa fragment of Helicobacter pylori vacuolating cytotoxin targets mitochondria and induces cytochrome c release. EMBO J. 19:6361-70
120. Willhite DC, Cover TL, Blanke SR. 2003. Cellular vacuolation and mitochondrial cytochrome c release are independent outcomes of Helicobacter pylori vacuolating cytotoxin activity that are each dependent on membrane channel formation. J. Biol. Chem. 278:48204-9
121. Nakayama M, Kimura M, Wada A, Yahiro K, Ogushi K, et al. 2004. Helicobacter pylori VacA activates the p38/activating transcription factor 2-mediated signal pathway in AZ-521 cells. J. Biol. Chem. 279:7024-28
122. Marchetti M, Arico B, Burroni D, Figura N, Rappuoli R, et al. 1995. Development of a mouse model of Helicobacter pylori infection that mimics human disease. Science 267:1655-58
123. Fujikawa A, Shirasaka D, Yamamoto S, Ota H, Yahiro K, et al. 2003. Mice deficient in protein tyrosine phosphatase receptor type Z are resistant to gastric ulcer induction by VacA of Helicobacter pylori. Nat. Genet. 33:375-81
124. de Bernard M, Cappon A, Pancotto L, Ruggiero P, Rivera J, et al. 2005. The Helicobacter pylori VacA cytotoxin activates RBL-2H3 cells by inducing cytosolic calcium oscillations. Cell. Microbiol. 7:191-98
125. Molinari M, Salio M, Galli C, Norais N, Rappuoli R, et al. 1998. Selective inhibition of Ii-dependent antigen presentation by Helicobacter pylori toxin VacA. J. Exp. Med. 187:135-40
126. Gebert B, Fischer W, Weiss E, Hoffmann R, Haas R. 2003. Helicobacter pylori vacuolating cytotoxin inhibits T lymphocyte activation. Science 301:1099-102
127. Boncristiano M, Paccani SR, Barone S, Ulivieri C, Patrussi L, et al. 2003. The Helicobacter pylori vacuolating toxin inhibits T cell activation by two independent mechanisms. J. Exp. Med. 198:1887-97
128. Sundrud MS, Torres VJ, Unutmaz D, Cover TL. 2004. Inhibition of primary human T cell proliferation by Helicobacter pylori vacuolating toxin (VacA) is independent of VacA effects on IL-2 secretion. Proc. Natl. Acad. Sci. USA 101:7727-32
129. Letley DP, Atherton JC. 2000. Natural diversity in the N terminus of the mature vacuolating cytotoxin of Helicobacter pylori determines cytotoxin activity. J. Bacteriol. 182:3278-80
130. McClain MS, Cao P, Iwamoto H, Vinion-Dubiel AD, Szabo G, et al. 2001. A 12-amino-acid segment, present in type s2 but not type s1 Helicobacter pylori VacA proteins, abolishes cytotoxin activity and alters membrane channel formation. J. Bacteriol. 183:6499-508
131. Aviles-Jimenez F, Letley DP, Gonzalez-Valencia G, Salama N, Torres J, et al. 2004. Evolution of the Helicobacter pylori vacuolating cytotoxin in a human stomach. J. Bacteriol. 186:5182-85
132. Boren T, Falk P, Roth KA, Larson G, Normark S. 1993. Attachment of Helicobacter pylori to human gastric epithelium mediated by blood-group antigens. Science 262:1892-95
133. Sheu BS, Sheu SM, Yang HB, Huang AH, Wu JJ. 2005. Host gastric Lewis expression determines the bacterial density of Helicobacter pylori in babA2 genopositive infection. Gut 52:927-32
134. Guruge JL, Falk PG, Lorenz RG, Dans M, Wirth HP, et al. 1998. Epithelial attachment alters the outcome of Helicobacter pylori infection. Proc. Natl. Acad. Sci. USA 95:3925-30
135. Mahdavi J, Sonden B, Hurtig M, Olfat FO, Forsberg L, et al. 2002. Helicobacter pylori SabA adhesin in persistent infection and chronic inflammation. Science 297:573-78
136. Ilver D, Arnqvist A, Ogren J, Frick IM, Kersulyte D, et al. 1998. Helicobacter pylori adhesin binding fucosylated histo-blood group antigens revealed by retagging. Science 279:373-77
137. Gerhard M, Lehn N, Neumayer N, Boren T, Rad R, et al. 1999. Clinical relevance of the Helicobacter pylori gene for blood-group antigen-binding adhesin. Proc. Natl. Acad. Sci. USA 96:12778-83
138. Prinz C, Schoniger M, Rad R, Becker I, Keiditsch E, et al. 2001. Key importance of the Helicobacter pylori adherence factor blood group antigen binding adhesin during chronic gastric inflammation. Cancer Res. 61:1903-9
139. Yu J, Leung WK, Go MYY, Chan MCW, To KF, et al. 2002. Relationship between Helicobacter pylori babA2 status with gastric epithelial cell turnover and premalignant gastric lesions. Gut 51:480-84
140. Solnick JV, Hansen LM, Salama NR, Boonjakuakul JK, Syvanen M. 2004. Modification of Helicobacter pylori outer membrane protein expression during experimental infection of rhesus macaques. Proc. Natl. Acad. Sci. USA 101:2106-11
141. Backstrom A, Lundberg C, Kersulyte D, Berg DE, Boren T, et al. 2004. Metastability of Helicobacter pylori bab adhesin genes and dynamics in Lewis b antigen binding. Proc. Natl. Acad. Sci. USA 101:16923-28
142. Hennig EE, Mernaugh R, Edl J, Cao P, Cover TL. 2004. Heterogeneity among Helicobacter pylori strains in expression of the outer membrane protein BabA. Infect. Immun. 72:3429-35
143. Yamaoka Y, Kwon DH, Graham DY. 2000. A M-r 34,000 proinflammatory outer membrane protein (oipA) of Helicobacter pylori. Proc. Natl. Acad. Sci. USA 97:7533-38
144. Peek RM, Thompson SA, Donahue JP, Tham KT, Atherton JC, et al. 1998. Adherence to gastric epithelial cells induces expression of a Helicobacter pylori gene, iceA, that is associated with clinical outcome. Proc. Assoc. Am. Physicians 110:531-44
145. Kidd M, Peek RM, Lastovica AJ, Israel DA, Kummer AF, et al. 2001. Analysis of iceA genotypes in South African Helicobacter pylori strains and relationship to clinically significant disease. Gut 49:629-35
146. Heithoff DM, Sinsheimer RL, Low DA, Mahan MJ. 1999. An essential role for DNA adenine methylation in bacterial virulence. Science 284:967-70
147. Xu Q, Blaser MJ. 2001. Promoters of the CATG-specific methyltransferase gene hpyIM differ between iceA1 and iceA2 Helicobacter pylori strains. J. Bacteriol. 183:3875-84
148. Ando T, Aras RA, Kusugami K, Blaser MJ, Wassenaar TM. 2003. Evolutionary history of hrgA, which replaces the restriction gene hpyIIIR in the hpyIII locus of Helicobacter pylori. J. Bacteriol. 185:295-301
149. Ando T, Wassenaar TM, Peek RM, Aras RA, Tschumi AI, et al. 2002. A Helicobacter pylori restriction endonuclease-replacing gene, hrgA, is associated with gastric cancer in Asian strains. Cancer Res. 62:2385-89
150. Hwang IR, Kodama T, Kikuchi S, Sakai K, Peterson LE, et al. 2002. Effect of interleukin 1 polymorphisms on gastric mucosal interleukin 1 beta production in Helicobacter pylori infection. Gastroenterology 123:1793-803
151. Rad R, Dossumbekova A, Neu B, Lang R, Bauer S, et al. 2004. Cytokine gene polymorphisms influence mucosal cytokine expression, gastric inflammation, and host specific colonisation during Helicobacter pylori infection. Gut 53:1082-89
152. Furuta T, El-Omar EM, Xiao F, Shirai N, Takashima M, et al. 2002. Interleukin 1 beta polymorphisms increase risk of hypochlorhydria and atrophic gastritis and reduce risk of duodenal ulcer recurrence in Japan. Gastroenterology 123:95-105
153. Machado JC, Figueiredo C, Canedo P, Nabais S, Alves CC, et al. 2003. A proinflammatory genetic profile increases the risk of chronic atrophic gastritis and gastric carcinoma. Gastroenterology 125:364-71
154. Rad R, Prinz C, Neu B, Neuhofer M, Zeitner M, et al. 2003. Synergistic effect of Helicobacter pylori virulence factors and interleukin-1 polymorphisms for the development of severe histological changes in the gastric mucosa. J. Infect. Dis. 188:272-81
155. El-Omar EM, Carrington M, Chow WH, McColl KEL, Bream JH, et al. 2000. Interleukin-1 polymorphisms associated with increased risk of gastric cancer. Nature 404:398-402
156. Machado JC, Pharoah P, Sousa S, Carvalho R, Oliveira C, et al. 2001. Interleukin 1B and interleukin 1RN polymorphisms are associated with increased risk of gastric carcinoma. Gastroenterology 121:823-29
157. El-Omar EM, Rabkin CS, Gammon MD, Vaughan TL, Risch HA, et al. 2003. Increased risk of noncardia gastric cancer associated with proinflammatory cytokine gene polymorphisms. Gastroenterology 124:1193-201
158. Garza-Gonzalez E, Bosques-Padilla FJ, El-Omar E, Hold G, Tijerina-Menchaca R, et al. 2005. Role of the polymorphic IL-1B, IL-1RN and TNF-A genes in distal gastric cancer in Mexico. Int. J. Cancer 114:237-41
159. Hsu PI, Li CN, Tseng HH, Lai KH, Hsu PN, et al. 2004. The Interleukin-1 RN polymorphism and Helicobacter pylori infection in the development of duodenal ulcer. Helicobacter 9:605-13
160. Ohyauchi M, Imatani A, Yonechi M, Asano N, Miura A, et al. 2005. The polymorphism interleukin 8-2251 A/T influences the susceptibility of Helicobacter pylori related gastric diseases in the Japanese population. Gut 54:330-35
161. Bamford KB, Fan X, Crowe SE, Leary JF, Gourley WK, et al. 1998. Lymphocytes in the human gastric mucosa during Helicobacter pylori have a T helper cell 1 phenotype. Gastroenterology 114:482-92
162. D'Elios MM, Manghetti M, De Carli M, Costa F, Baldari CT, et al. 1997. T helper 1 effector cells specific for Helicobacter pylori in the gastric antrum of patients with peptic ulcer disease. J. Immunol. 158:962-67
163. Mohammadi M, Nedrud J, Redline R, Lycke N, Czinn SJ. 1997. Murine CD4 T-cell response to Helicobacter infection: TH1 cells enhance gastritis and TH2 cells reduce bacterial load. Gastroenterology 113:1848-57
164. Smythies LE, Waites KB, Lindsey JR, Harris PR, Ghiara P, et al. 2000. Helicobacter pylori-induced mucosal inflammation is Th1 mediated and exacerbated in IL-4, but not IFN-gamma, gene-deficient mice. J. Immunol. 165:1022-29
165. Yamori M, Yoshida M, Watanabe T, Shirai Y, Iizuka T, et al. 2004. Antigenic activation of Th1 cells in the gastric mucosa enhances dysregulated apoptosis and turnover of the epithelial cells. Biochem. Biopbys. Res. Commun. 316:1015-21
166. Cui G, Houghton J, Finkel N, Carlson J, Wang TC. 2003. IFN-gamma infusion induces gastric atrophy, metaplasia and dysplasia in the absence of Helicobacter pylori infection - a role for the immune response in Helicobacter disease. Gastroenterology 2003:A19
167. Mohammadi M, Czinn S, Redline R, Nedrud J. 1996. Helicobacter-specific cell-mediated immune responses display a predominant Th1 phenotype and promote a delayed-type hypersensitivity response in the stomachs of mice. J. Immunol. 156:4729-38
168. Obonyo M, Guiney DG, Harwood J, Fierer J, Cole SP. 2002. Role of gamma interferon in Helicobacter pylori induction of inflammatory mediators during murine infection. Infect. Immun. 70:3295-99
169. Guiney DG, Hasegawa P, Cole SP. 2003. Helicobacter pylori preferentially induces interleukin 12 (IL-12) rather than IL-6 or IL-10 in human dendritic cells. Infect. Immun. 71:4163-66
170. Kranzer K, Eckhardt A, Aigner M, Knoll G, Demi L, et al. 2004. Induction of maturation and cytokine release of human dendritic cells by Helicobacter pylori. Infect. Immun. 72:4416-23
171. Galgani M, Busiello I, Censini S, Zappacosta S, Racioppi L, et al. 2004. Helicobacter pylori induces aptosis of human monocytes but not monocyte-derived dendritic cells: role of the cag pathogenicity island. Infect. Immun. 72:4480-85
172. Fox JG, Beck P, Dangler CA, Whary MT, Wang TC, et al. 2000. Concurrent enteric helminth infection modulates inflammation and gastric immune responses and reduces helicobacter-induced gastric atrophy. Nat. Med. 6:536-42
173. Foryst-Ludwig A, Naumann M. 2000. p21-activated kinase 1 activates the nuclear factor kappa B (NF-kappa B)-inducing kinase-Ikappa B kinases NF-kappa B pathway and proinflammatory cytokines in Helicobacter pylori infection. J. Biol. Chem. 275:39779-85
174. Girardin SE, Boneca IG, Carneiro LAM, Antignac A, Jehanno M, et al. 2003. Nod1 detects a unique muropeptide from Gram-negative bacterial peptidoglycan. Science 300:1584-87
175. Bergman MP, Engering A, Smits HH, van Vliet SJ, van Bodegraven AA, et al. 2004. Helicobacter pylori modulates the T helper cell 1/T helper cell 2 balance through phase-variable interaction between lipopolysaccharide and DC-SIGN. J. Exp. Med. 200:979-90
176. Meyer F, Ramanujam KS, Gobert AP, James SP, Wilson KT. 2003. Cutting edge: cyclooxygenase-2 activation suppresses Th1 polarization in response to Helicobacter pylori. J. Immunol. 171:3913-17
177. Lundgren A, Suri-Payer E, Enarsson K, Svennerholm AM, Lundin BS. 2003. Helicobacter pylon-specific CD4(+) CD25(high) regulatory T cells suppress memory T-cell responses to H. pylori in infected individuals. Infect. Immun. 71:1755-62
178. Moss SF, Legon S, Bishop AE, Polak JM, Calam J. 1992. Effect of Helicobacter pylori on gastric somatostatin in duodenal-ulcer disease. Lancet 340:930-2
179. Beales I, Calam J, Post L, Srinivasan S, Yamada T, et al. 1997. Effect of transforming growth factor alpha and interleukin 8 on somatostatin release from canine fundic D cells. Gastroenterology 112:136-43
180. Odum L, Petersen HD, Andersen IB, Hansen BF, Rehfeld JF, et al. 1994. Gastrin and somatostatin in Helicobacter pylori infected antral mucosa. Gut 35:615-18
181. Arebi N, Healey ZV, Bliss PW, Ghatei M, Van Noorden S, et al. 2002. Nitric oxide regulates the release of somatostatin from cultured gastric rabbit primary D-cells. Gastroenterology 123:566-76
182. Zavros Y, Rathinavelu S, Kao JY, Todisco A, Del Valle J, et al. 2003. Treatment of Helicobacter gastritis with IL-4 requires somatostatin. Proc. Natl. Acad. Sci. USA 100:12944-49
183. Wang TC, Dangler CA, Chen D, Goldenring JR, Koh T, et al. 2000. Synergistic interaction between hypergastrinemia and Helicobacter infection in a mouse model of gastric cancer. Gastroenterology 118:36-47
184. Peek RM, Wirth HP, Moss SF, Yang MQ, Abdalla AM, et al. 2000. Helicobacter pylori alters gastric epithelial cell cycle events and gastrin secretion in Mongolian gerbils. Gastroenterology 118:48-59
185. Guo YS, Cheng JZ, Jin GF, Gutkind JS, Hellmich MR, et al. 2002. Gastrin stimulates cyclooxygenase-2 expression in intestinal epithelial cells through multiple signaling pathways - evidence for involvement of Erk5 kinase and transactivation of the epidermal growth factor receptor. J. Biol. Chem. 277:48755-63
186. Fukui H, Franceschi F, Penland RL, Sakai T, Sepulveda AR, et al. 2003. Effects of Helicobacter pylori infection on the link between regenerating gene expression and serum gastrin levels in Mongolian gerbils. Lab. Invest. 83:1777-86
187. Azuma T, Suto H, Ito Y, Ohtani M, Dojo M, et al. 2001. Gastric leptin and Helicobacter pylori infection. Gut 49:324-29
188. Breidert M, Miehlke S, Glasow A, Orban Z, Stolte M, et al. 1999. Leptin and its receptor in normal human gastric mucosa and in Helicobacter pylori-associated gastritis. Scand. J. Gastroenterol. 34:954-61
189. Nwokolo CU, Freshwater DA, O'Hare P, Randeva HS. 2003. Plasma ghrelin following cure of Helicobacter pylori. Gut 52:637-40
190. Atherton JC, Tham KT, Peek RM, Cover TL, Blaser MJ. 1996. Density of Helicobacter pylori infection in vivo as assessed by quantitative culture and histology. J. Infect. Dis. 174:552-56
191. Gillen D, El-Omar EM, Wirz AA, Ardill JES, McColl KEL. 1998. The acid response to gastrin distinguishes duodenal ulcer patients from Helicobacter pylori-infected healthy subjects. Gastroenterology 114:50-57
192. Hamlet A, Olbe L. 1996. The influence of Helicobacter pylori infection on postprandial duodenal acid load and duodenal bulb pH in humans. Gastroenterology 111:391-400
193. Khulusi S, Badve S, Patel P, Lloyd R, Marrero JM, et al. 1996. Pathogenesis of gastric metaplasia of the human duodenum: role of Helicobacter pylori, gastric acid, and ulceration. Gastroenterology 110:452-58
194. Van Zanten S, Dixon MF, Lee A. 1999. The gastric transitional zones: neglected links between gastroduodenal pathology and Helicobacter ecology. Gastroenterology 116:1217-29
195. Amedei A, Bergman MP, Appelmelk BJ, Azzurri A, Benagiano M, et al. 2003. Molecular mimicry between Helicobacter pylori antigens and H+, K+-adenosine triphosphatase in human gastric autoimmunity. J. Exp. Med. 198:1147-56
196. ElOmar EM, Oien K, ElNujumi A, Gillen D, Wirz A, et al. 1997. Helicobacter pylori infection and chronic gastric acid hyposecretion. Gastroenterology 113:15-24
197. Beales ILP, Calam J. 1998. Interleukin 1 beta and tumour necrosis factor alpha inhibit acid secretion in cultured rabbit parietal cells by multiple pathways. Gut 42:227-34
198. Padol IT, Hunt RH. 2004. Effect of Th1 cytokines on acid secretion in pharmacologically characterised mouse gastric glands. Gut 53:1075-81
199. Kuipers EJ, Uyterlinde AM, Pena AS, Hazenberg HJA, Bloemena E, et al. 1995. Increase of Helicobacter pylori-associated corpus gastritis during acid suppressive therapy-implications for long-term safety. Am. J. Gastroenterol. 90:1401-6
200. Zavros Y, Rieder G, Ferguson A, Samuelson LC, Merchant JL. 2002. Hypergastrinemia in response to gastric inflammation suppresses somatostatin. Am. J. Physiol. Gastrointest. Liver Physiol. 282:G175-G83
201. Wong BCY, Lam SK, Wong WM, Chen JS, Zheng TT, et al. 2004. Helicobacter pylori eradication to prevent gastric cancer in a high-risk region of China - a randomized controlled trial. JAMA 291:187-94
202. Touati E, Michel V, Thiberge JM, Wuscher N, Huerre M, et al. 2003. Chronic Helicobacter pylori infections induce gastric mutations in mice. Gastroenterology 124:1408-19
203. Nam KT, Oh SY, Ahn B, Kim YB, Jang DD, et al. 2004. Decreased Helicobacter pylori associated gastric carcinogenesis in mice lacking inducible nitric oxide synthase. Gut 53:1250-55
204. Correa P, Fontham ETH, Bravo JC, Bravo LE, Ruiz B, et al. 2000. Chemoprevention of gastric dysplasia: randomized trial of antioxidant supplements and anti-Helicobacter pylori therapy. J. Natl. Cancer Inst. 92:1881-88
205. You WC, Zhang L, Gail MH, Chang YS, Liu WD, et al. 2000. Gastric cancer: Helicobacter pylori, serum vitamin C, and other risk factors. J. Natl. Cancer Inst. 92:1607-12
206. Dimmler A, Brabletz T, Hlubek F, Hafner M, Rau T, et al. 2003. Transcription of sonic hedgehog, a potential factor for gastric morphogenesis and gastric mucosa maintenance, is up-regulated in acidic conditions. Lab. Invest. 83:1829-37
207. Syder AJ, Oh JD, Guruge JL, O'Donnell D, Karlsson M, et al. 2003. The impact of parietal cells on Helicobacter pylori tropism and host pathology: an analysis using gnotobiotic normal and transgenic mice. Proc. Natl. Acad. Sci. USA 100:3467-72
208. Nomura S, Baxter T, Yamaguchi H, Leys C, Vartapetian AB, et al. 2004. Spasmolytic polypeptide expressing metaplasia to preneoplasia in H-felis-infected mice. Gastroenterology 127:582-94
209. Mutoh H, Sakurai S, Satoh K, Tamada K, Kita H, et al. 2004. Development of gastric carcinoma from intestinal metaplasia in CDx2-transgenic mice. Cancer Res. 64:7740-47
210. Houghton J, Stoicov C, Nomura S, Rogers AB, Carlson J, et al. 2004. Gastric cancer originating from bone marrow-derived cells. Science 306:1568-71
211. Lauren P. 1965. 2 Histological main types of gastric carcinoma-diffuse and so-called intestinal-type carcinoma-an attempt at a histo-clinical classification. Acta Pathol. Microbiol. Scand. 64:31-49
212. Leung WK, Lin SR, Ching JYL, To KF, Ng EKW, et al. 2004. Factors predicting progression of gastric intestinal metaplasia: results of a randomised trial on Helicobacter pylori eradication. Gut 53:1244-49
213. Semino-Mora C, Doi SQ, Marty A, Simko V, Carlstedt I, et al. 2003. Intracellular and interstitial expression of Helicobacter pylori virulence genes in gastric precancerous intestinal metaplasia and adenocarcinoma. J. Infect. Dis. 187:1165-77
214. Wagner S, Beil W, Westermann J, Logan RPH, Bock CT, et al. 1997. Regulation of gastric epithelial cell growth by Helicobacter pylori: evidence for a major role of apoptosis. Gastroenterology 113:1836-47
215. Ashktorab H, Frank S, Khaled AR, Durum SK, Kifle B, et al. 2004. Bax translocation and mitochondrial fragmentation induced by Helicobacter pylori. Gut 53:805-13
216. Eguchi H, Carpentier S, Kim SS, Moss SF. 2004. p27(kip1) regulates the apoptotic response of gastric epithelial cells to Helicobacter pylori. Gut 53:797-804
217. Jones NL, Day AS, Jennings H, Shannon PT, Galindo-Mata E, et al. 2002. Enhanced disease severity in Helicobacter pylori-infected mice deficient in Fas signaling. Infect. Immun. 70:2591-97
218. Obst B, Wagner S, Sewing KF, Beil W. 2000. Helicobacter pylori causes DNA damage in gastric epithelial cells. Carcinogenesis 21:1111-15
219. Kim JJ, Tao H, Carloni E, Leung WK, Graham DY, et al. 2002. Helicobacter pylori impairs DNA mismatch repair in gastric epithelial cells. Gastroenterology 123:542-53
220. Smoot DT, Elliott TB, Verspaget HW, Jones D, Allen CR, et al. 2000. Influence of Helicobacter pylori on reactive oxygen-induced gastric epithelial cell injury. Carcinogenesis 21:2091-95
221. Ding SZ, O'Hara AM, Denning TL, Dirden-Kramer B, Mifflin RC, et al. 2004. Helicobacter pylori and H2O2 increase AP endonuclease-1/redox factor-1 expression in human gastric epithelial cells. Gastroenterology 127:845-58
222. Nagata K, Yu H, Nishikawa M, Kashiba M, Nakamura A, et al. 1998. Helicobacter pylori generates superoxide radicals and modulates nitric oxide metabolism. J. Biol. Chem. 273:14071-73
223. O'Rourke EJ, Chevalier C, Pinto AV, Thiberge JM, Ielpi L, et al. 2003. Pathogen DNA as target for host-generated oxidative stress: role for repair of bacterial DNA damage in Helicobacter pylori colonization. Proc. Natl. Acad. Sci. USA 100:2789-94
224. el-Serag HB, Sonnenberg A. 1998. Opposing time trends of peptic ulcer and reflux disease. Gut 43:327-33
225. Yamaji Y, Mitsushima T, Ikuma H, Okamoto M, Yoshida H, et al. 2001. Inverse background of Helicobacter pylori antibody and pepsinogen in reflux oesophagitis compared with gastric cancer: analysis of 5732 Japanese subjects. Gut 49:335-40
226. Ye WM, Held M, Lagergren J, Engstrand L, Blot WJ, et al. 2004. Helicobacter pylori infection and gastric atrophy: risk of adenocarcinoma and squamous-cell carcinoma of the esophagus and adenocarcinoma of the gastric cardia. J. Natl. Cancer Inst. 96:388-96
227. de Martel C, Llosa AE, Farr SM, Friedman GD, Vogelman JH, et al. 2005. Helicobacter pylori infection and the risk of development of esophageal adenocarcinoma. J. Infect. Dis. 191:761-67
228. Warburton-Timms VJ, Charlett A, Valori RM, Uff JS, Shepherd NA, et al. 2001. The significance of cagA(+) Helicobacter pylori in reflux oesophagitis. Gut 49:341-46
229. Chow WH, Blaser MJ, Blot WJ, Gammon MD, Vaughan TL, et al. 1998. An inverse relation between cagA+ strains of Helicobacter pylori infection and risk of esophageal and gastric cardia adenocarcinoma. Cancer Res. 58:588-90
230. Vaezi MF, Falk GW, Peek RM, Vicari JJ, Goldblum JR, et al. 2000. CagA-positive strains of Helicobacter pylori may protect against Barrett's esophagus. Am. J. Gastroenterol. 95:2206-11
231. El-Serag HB, Sonnenberg A, Jamal MM, Inadomi JM, Crooks LA, et al. 1999. Corpus gastritis is protective against reflux oesophagitis. Gut 45:181-85
232. Koike T, Ohara S, Sekine H, Iijima K, Abe Y, et al. 2001. Helicobacter pylori infection prevents erosive reflux oesophagitis by decreasing gastric acid secretion. Gut 49:330-34
233. Rothenbacher D, Blaser MJ, Bode G, Brenner H. 2000. Inverse relationship between gastric colonization of Helicobacter pylori and diarrheal illnesses in children: results of a population-based cross-sectional study. J. Infect. Dis. 182:1446-49
234. Wang G, Ge ZM, Rasko A, Taylor DE. 2000. Lewis antigens in Helicobacter pylori: biosynthesis and phase variation. Mol. Microbiol. 36:1187-96
235. Baron JH, Sonnenberg A. 2001. Period- and cohort-age contours of deaths from gastric and duodenal ulcer in New York 1804-1998. Am. J. Gastroenterol. 96:2887-91
236. Susser S. 1962. Civilisation and peptic ulcer. Lancet 1:115-18
237. deJong D, vanderHulst RWM, Pals G, vanDijk WC, vanderEnde A, et al. 1996. Gastric non-Hodgkin lymphomas of mucosa-associated lymphoid tissue are not associated with more aggressive Helicobacter pylori strains as identified by CagA. Am. J. Clin. Pathol. 106:670-75
238. Peng HZ, Ranaldi R, Diss TC, Isaacson PG, Bearzi I, et al. 1998. High frequency of CagA+ Helicobacter pylori infection in high-grade gastric MALT B-cell lymphomas. J. Pathol. 185:409-12
239. Delchier JC, Lamarque D, Levy M, Tkoub EM, Copie-Bergman C, et al. 2001. Helicobacter pylori and gastric lymphoma: high seroprevalence of CagA in diffuse large B-cell lymphoma but not in low-grade lymphoma of mucosa-associated lymphoid tissue type. Am. J. Gastroenterol. 96:2324-28
240. Lehours P, Menard A, Dupouy S, Bergey B, Richy F, et al. 2004. Evaluation of the association of nine Helicobacter pylori virulence factors with strains involved in low-grade gastric mucosa-associated lymphoid tissue lymphoma. Infect. Immun. 72:880-88
241. Miehlke S, Yu J, Schuppler M, Frings C, Kirsch C, et al. 2001. Helicobacter pylori vacA, iceA, and cagA status and pattern of gastritis in patients with malignant and benign gastroduodenal disease. Am. J. Gastroenterol. 96:1008-13
242. Hussell T, Isaacson PG, Crabtree JE, Spencer J. 1993. The response of cells from low-grade B-cell gastric lymphomas of mucosa-associated lymphoid-tissue to Helicobacter pylori. Lancet 342:571-74
243. Du M, Diss TC, Xu C, Peng H, Isaacson PG, et al. 1996. Ongoing mutation in MALT lymphoma immunoglobulin gene suggests that antigen stimulation plays a role in the clonal expansion. Leukemia 10:1190-97
244. Wotherspoon AC, Doglioni C, Diss TC, Pan LX, Moschini A, et al. 1993. Regression of primary low-grade B-cell gastric lymphoma of mucosa-associated lymphoid-tissue type after eradication of Helicobacter pylori. Lancet 342:575-77
245. Fischbach W, Goebeler-Kolve ME, Dragosics B, Greiner A, Stolte M. 2004. Long term outcome of patients with gastric marginal zone B cell lymphoma of mucosa associated lymphoid tissue (MALT) following exclusive Helicobacter pylori eradication therapy: experience from a large prospective series. Gut 53:34-37
246. Ott G, Katzenberger T, Greiner A, Kalla J, Rosenwald A, et al. 1997. The t(11;18)(q21;q21) chromosome translocation is a frequent and specific aberration in low-grade but not high-grade malignant non-Hodgkin's lymphomas of the mucosa-associated lymphoid tissue (MALT-) type. Cancer Res. 57:3944-48
247. Auer IA, Gascoyne RD, Connors JM, Cotter FE, Greiner TC, et al. 1997. t(11;18) (q21;q21) is the most common translocation in MALT lymphomas. Ann. Oncol. 8:979-85
248. Dierlamm J, Baens M, Wlodarska I, Stefanova-Ouzounova M, Hernandez JM, et al. 1999. The apoptosis inhibitor gene API2 and a novel 18q gene, MLT, are recurrently rearranged in the t(11;18)(q21;q21) associated with mucosa-associated lymphoid tissue lymphomas. Blood 93:3601-9
249. Lucas PC, Yonezumi M, Inohara N, McAllister-Lucas LM, Abazeed ME, et al. 2001. Bcl10 and MALT1, independent targets of chromosomal translocation in MALT lymphoma, cooperate in a novel NF-kappa B signaling pathway. J. Biol. Chem. 276:19012-19
250. Liu HX, Ruskon-Fourmestraux A, Lavergne-Slove A, Ye HT, Molina T, et al. 2001. Resistance of t(11;18) positive gastric mucosa-associated lymphoid tissue lymphoma to Helicobacter pylori eradication therapy. Lancet 357:39-40
251. Liu HX, Ye HT, Ruskone-Fourmestraux A, de Jong D, Pileri S, et al. 2001. t(11;18) is a marker for ail stage gastric MALT lymphomas that will not respond to H. pylori eradication. Blood 98:767A
252. Ye HT, Liu HX, Attygalle A, Wotherspoon AC, Nicholson AG, et al. 2003. Variable frequencies of t(11;18)(q21;q21) in MALT lymphomas of different sites: significant association with CagA strains of H. pylori in gastric MALT lymphoma. Blood 102:1012-18